PolyNovo Limited (PNV.AX)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Swami Raote BPHARM, M.B.A. | CEO & Director | 756.17k | -- | -- |
| Mr. Jan-Marcel Gielen C.A. | Chief Financial Officer | 371.95k | -- | -- |
| Dr. David McQuillan Ph.D. | Chief Technical & Scientific Officer | 392.6k | -- | -- |
| Mr. Philip Scorgie | Chief Information Officer | 275.58k | -- | -- |
| Mr. Ahmed Hassan | Director of Operations | -- | -- | -- |
| Mr. Lior Harel | General Counsel & Company Secretary | -- | -- | -- |
| Ms. Ingrid Anderson | Chief People Officer | -- | -- | -- |
| Mr. Edward Graubart | President of North America | -- | -- | -- |
| Dr. Joseph F. Amaral M.D. | Chief Medical Officer | -- | -- | 1956 |
| Mr. David N. Morris BAppSc, BBus | President of Asia Pacific | -- | -- | -- |
PolyNovo Limited
- Sector:?
- Healthcare
- Industry:? Medical Devices
- Full Time Employees:?
- 254
Description
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Corporate Governance
Upcoming Events
August 22, 2024 at 10:30 PM UTC
PolyNovo Limited Earnings Date
Recent Events
Recent Events Information Not Available